Ly49P Recognition of Cytomegalovirus-infected Cells Expressing H2-Dk and CMV-encoded M04 Correlates with the NK Cell Antiviral Response
Overview
General Medicine
Authors
Affiliations
Natural killer (NK) cells are crucial in resistance to certain viral infections, but the mechanisms used to recognize infected cells remain largely unknown. Here, we show that the activating Ly49P receptor recognizes cells infected with mouse cytomegalovirus (MCMV) by a process that requires the presence of H2-D(k) and the MCMV m04 protein. Using H2 chimeras between H2-D(b) and -D(k), we demonstrate that the H2-D(k) peptide-binding platform is required for Ly49P recognition. We identified m04 as a viral component necessary for recognition using a panel of MCMV-deletion mutant viruses and complementation of m04-deletion mutant (Deltam04) virus infection. MA/My mice, which express Ly49P and H2-D(k), are resistant to MCMV; however, infection with Deltam04 MCMV abrogates resistance. Depletion of NK cells in MA/My mice abrogates their resistance to wild-type MCMV infection, but does not significantly affect viral titers in mice infected with Deltam04 virus, implicating NK cells in host protection through m04-dependent recognition. These findings reveal a novel mechanism of major histocompatibility complex class I-restricted recognition of virally infected cells by an activating NK cell receptor.
Emerging Insights into Memory Natural Killer Cells and Clinical Applications.
Kokici J, Preechanukul A, Arellano-Ballestero H, Gorou F, Peppa D Viruses. 2024; 16(11).
PMID: 39599860 PMC: 11599065. DOI: 10.3390/v16111746.
Cis-regulatory evolution of the recently expanded Ly49 gene family.
Fan C, Xing X, Murphy S, Poursine-Laurent J, Schmidt H, Parikh B Nat Commun. 2024; 15(1):4839.
PMID: 38844462 PMC: 11156856. DOI: 10.1038/s41467-024-48990-y.
Themis2 regulates natural killer cell memory function and formation.
Nabekura T, Deborah E, Tahara S, Arai Y, Love P, Kako K Nat Commun. 2023; 14(1):7200.
PMID: 37938555 PMC: 10632368. DOI: 10.1038/s41467-023-42578-8.
Holt E, Waytashek C, Sessions K, Asarian L, Lahue K, Usherwood E J Immunol. 2023; 211(10):1526-1539.
PMID: 37819784 PMC: 10841120. DOI: 10.4049/jimmunol.2300294.
Shegarfi H Innate Immun. 2023; 29(6):110-121.
PMID: 37285590 PMC: 10468624. DOI: 10.1177/17534259231178223.